Blood pressure reducing medications containing valsartam, an active ingredient produced by China's Zhejiang Huahai Pharmaceuticals, are being recalled in Lithuania as they may contain impurities capable of causing cancer.
© DELFI / Karolina Pansevič

Žydrūnas Martinėnas, deputy director of Lithuania's State Medicines Control Agency, told BNS Lithuania that the potential risk of the identified impurities is being assessed by the European Medicines Agency.

In his words, there are market alternatives with the same active ingredient to the recalled medications.

"New medications should be prescribed by the doctor," Martinėnas told BNS Lithuania.

The medications might have been contaminated with impurities during the manufacturing process, the Lithuania's State Medicines Control Agency said.

BNS
It is prohibited to copy and republish the text of this publication without a written permission from UAB „BNS“.
Leave a comment
or for anonymous commenting click here
By posting, you agree to terms
Read comments Read comments

4 reasons why you should start looking for Christmas presents right now

With three more months still to go until the most beautiful holiday of the year, you should really...

The court has made a decision – “Jacquet” instead of “Žakė“

After examining the case of the records of surnames of a children with dual citizenship in the records...

Time for those dearest to us: one hour a week is not enough

In September, when the family rythm returns to its routine pace there is increasingly less time left...

Names of Holocaust victims to be read out in Seimas

Names of the Holocaust victims will be read out in the Lithuanian parliament on Monday to mark the...

Papal visit to Lithuania: ten most memorable quotes

Pope Francis visited Lithuania on Saturday and Sunday. BNS Lithuania provides ten most memorable...